北美外部药物 CDMO 市场规模、份额和趋势分析报告：按产品类型、服务类型、赞助商、国家和细分市场进行预测，2024-2030 年

北美外用药物 CDMO 市场成长与趋势：

Grand View Research, Inc.最新报告显示，到2030年，北美主题CDMO市场规模预计将达到264.5亿美元，2024年至2030年复合年增长率为10.7%。

对研发活动的投资不断增加，以及对多种皮肤病新疗法的需求不断增长，导致局部 CDMO 市场的需求不断增长。由于易于管理和最小的副作用，消费者对多种局部解决方案的偏好增加也是支持市场成长的因素。

对新颖创新和新产品开发的需求不断增长预计将改善市场需求，而竞争压力和价格担忧则鼓励公司外包开发新药和製造。预计这将推动整体市场的成长。此外，CDMO 利用奈米技术等先进技术在分子层面上操纵药物颗粒，以提高药物稳定性和生物有效性。此外，微胶囊技术可以保护敏感成分，并实现控制释放和标靶药物输送，从而提高治疗效果。这些技术进步正在加速北美市场的成长潜力。

CDMO积极参与与製药公司的合作和伙伴关係，并已获得创新药物开发和多种外用製剂生产的长期合同，预计将推动市场需求。例如，2023 年 1 月，专门从事外用皮肤产品的着名供应商瑞美国CDMO 与 EveryDrop 分配平台的发明者 LiquiGlide 合作。透过此次合作，该公司将利用 LiquiGlide 的创新无毒光滑表面技术来消除液体和固体之间的摩擦，从而消除消费包装商品的产品废弃物。

北美专题 CDMO 市场报告亮点：

• 从产品类型来看，半固态製剂领域占据市场主导地位，2023年销售份额将超过65.0%。这是因为与口服给药途径相比，由于一些副作用，外用药物具有许多优点，例如易于给药以及患者更喜欢外用药物，这正在推动该领域的需求。
• 按服务类型划分，契约製造预计在预测期内将以显着的复合年增长率成长。
• 按赞助商划分，2023 年製药公司占最大市场占有率。製药公司对创新外用药物的开发和商业化的开拓投资预计将推动市场收益成长。
• 由于该地区强大的市场参与企业、政府对优质医疗保健的支持以及对化妆品的高需求等因素，美国在北美局部 CDMO 行业中占据主导地位。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章 北美专题 CDMO 市场变数、趋势与范围

• 市场体系展望
  • 母市场展望
• 市场动态
  • 市场驱动因素分析
  • 市场限制因素分析
• 北美外用药物CDMO市场分析工具
  • 产业分析-波特五力分析
  • PESTEL分析
• 价格分析
• 外用药物 CDMO 产能展望
• 按产品类型的北美外用药物 CDMO 市场前景
• COVID-19 大流行的影响

第四章 北美外用药物CDMO市场：产品类型估算及趋势分析

• 2023 年及 2030 年产品类型市场占有率
• 细分仪表板
• 北美外用药品 CDMO 市场的产品展望
• 2018年至2030年市场规模、预测与趋势分析

第五章北美外用药物CDMO市场：服务类型估算及趋势分析

• 2023 年及 2030 年服务类型市场占有率
• 细分仪表板
• 按服务类型分類的北美外用药物 CDMO 市场前景
• 2018年至2030年市场规模、预测与趋势分析

第六章 北美外用药物 CDMO 市场：申办方估计与趋势分析

• 2023年及2030年赞助市场占有率
• 细分仪表板
• 北美外用药品 CDMO 市场赞助商展望
• 2018年至2030年市场规模、预测与趋势分析

第七章 北美外用药物 CDMO 市场：国家估计与趋势分析

• 2023 年及 2030 年国家市场占有率分析
• 国家市场仪表板
• 国家市场概述
• 2018-2030年市场规模及预测趋势分析
• 美国
• 加拿大

第八章 竞争形势

• 公司/竞争对手分类
  • 创新者
  • 市场领导者
  • 新兴玩家
  • 2023 年公司市场占有率分析
• 公司简介
  • The Lubrizol Corporation
  • Cambrex Corporation
  • Contract Pharmaceuticals Limited
  • Bora Pharmaceutical CDMO
  • Ascendia Pharmaceuticals
  • Pierre Fabre SA
  • Piramal Pharma Solutions
  • DPT Laboratories, LTD.
  • MedPharm Ltd.
  • Zenvisionpharma

North America Topical Drugs CDMO Market Growth & Trends:

The North America topical drugs CDMO market size is anticipated to reach USD 26.45 billion by 2030, registering a CAGR of 10.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing investment in R&D activities coupled with rising need for novel therapeutics for several dermatological conditions contributes to the growing demand for topical drugs CDMO market. Rising consumer preference for several topical solutions owing to ease of administration and minimized side effects are other factors supporting the growth of the market.

The growing need for novel innovation and new product developments are expected to improve the demand in the market, and competitive pressure & pricing concerns are driving companies to outsource new drug development & manufacturing. This is expected to drive overall market growth. Moreover, CDMOs are leveraging several advanced technologies such as nanotechnology to manipulate drug particles at the molecular level, enhancing drug stability and bioavailability. Moreover, microencapsulation techniques protect sensitive ingredients, allowing for controlled release and targeted drug delivery, amplifying therapeutic outcomes. Such technological advancements are accelerating market growth potential in North America.

CDMOs are actively involved in collaboration & partnerships with pharmaceutical companies to secure long-term contracts for innovative drug development and manufacturing of several topical formulations, which is expected to spur market demand. For instance, in January 2023, Swiss-American CDMO, a prominent provider specializing in topical skin care products, collaborated with LiquiGlide, the inventor of the EveryDrop dispensing platform. Through this collaboration, the company will utilize LiquiGlide's innovative nontoxic slippery surface technology to eliminate friction between liquids & solids and product waste for consumer-packaged goods.

North America Topical Drugs CDMO Market Report Highlights:

• Based on product type, the semi-solid formulations segment dominated the market with a revenue share of more than 65.0% share in 2023, owing to numerous advantages including ease of administration and patient preference for topical drugs compared to the oral route of administration owing to several adverse effects, which is expected to drive segment demand
• Based on service type, the contract manufacturing segment is expected to grow at the substantial CAGR over the forecast period
• Based on sponsors, the pharmaceutical companies segment held the largest market share in 2023. Growing R&D investments by several pharmaceutical companies to develop and commercialize innovative topical drugs is anticipated to boost market revenue growth
• The U.S. dominated the North America topical drugs CDMO industry owing to factors such as strong presence of market participants in the region, government support for quality healthcare and high demand for cosmetic products

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
• 1.5. Details of primary research
  • 1.5.1. Data for primary interviews in the U.S.
  • 1.5.2. Data for primary interviews in Canada
• 1.6. Information or Data Analysis
  • 1.6.1. Data analysis models
• 1.7. Market Formulation & Validation
• 1.8. Model Details
  • 1.8.1. Commodity flow analysis (Model 1)
  • 1.8.2. Approach 1: Commodity flow approach
  • 1.8.3. Parent Market Analysis (Model 2)
  • 1.8.4. Approach 2: Parent Market Analysis
• 1.9. List of Secondary Sources
• 1.10. List of Primary Sources
• 1.11. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. North America Topical Drugs CDMO Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Technological advancements & growing R&D investments
    • 3.2.1.2. Rising demand for topical medications
    • 3.2.1.3. Expansion of manufacturing capacities and partnerships
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Compliance with strict regulatory requirements
    • 3.2.2.2. Limited efficacy in certain conditions limits adoption of topical products
• 3.3. North America Topical Drugs CDMO Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis
• 3.4. Pricing Analysis
• 3.5. Topical Drugs CDMO Capacity Outlook
  • 3.5.1. CDMO Manufacturing Container Capacity
  • 3.5.2. Topical Drugs Container Capacity By Product Type
• 3.6. North America Topical Drugs CDMO Market Outlook By Product Category
  • 3.6.1. North America Topical Drugs CDMO Market Share, By Product Category, 2023 (%)
  • 3.6.2. Prescription Drugs
    • 3.6.2.1. Segment Overview
    • 3.6.2.2. Major Prescription Drugs, By Product Type
  • 3.6.3. Generic Drugs
    • 3.6.3.1. Segment Overview
    • 3.6.3.2. Major Generic Drugs, By Product Type
  • 3.6.4. Over-the-counter (OTC) Drugs
    • 3.6.4.1. Segment Overview
    • 3.6.4.2. Major OTC Drugs, By Product Type
• 3.7. Impact of COVID-19 Pandemic

Chapter 4. North America Topical Drugs CDMO Market: Product Type Estimates & Trend Analysis

• 4.1. Product Type Market Share, 2023 & 2030
• 4.2. Segment Dashboard
• 4.3. North America Topical Drugs CDMO Market by Product Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.4.1. Semi-solid Formulations
    • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.2. Creams
    • 4.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.3. Ointments
    • 4.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.4. Lotions
    • 4.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.5. Others
    • 4.4.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.2. Liquid Formulations
    • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2.2. Suspensions
    • 4.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2.3. Solutions
    • 4.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.3. Solid Formulations
    • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.4. Transdermal Products
    • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. North America Topical Drugs CDMO Market: Service Type Estimates & Trend Analysis

• 5.1. Service Type Market Share, 2023 & 2030
• 5.2. Segment Dashboard
• 5.3. North America Topical Drugs CDMO Market by Service Outlook
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.4.1. Contract Development
    • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.1.2. Formulation Development
    • 5.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.1.3. Analytical Testing
    • 5.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.1.4. Stability Testing
    • 5.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.1.5. Others
    • 5.4.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.2. Contract Manufacturing
    • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2.2. Clinical
    • 5.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2.3. Commercial
    • 5.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. North America Topical Drugs CDMO Market: Sponsors Estimates & Trend Analysis

• 6.1. Sponsors Market Share, 2023 & 2030
• 6.2. Segment Dashboard
• 6.3. North America Topical Drugs CDMO Market by Sponsors Outlook
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.4.1. Pharmaceutical Companies
    • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.2. Biopharmaceutical Companies
    • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.3. Others
    • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. North America Topical Drugs CDMO Market: Country Estimates & Trend Analysis

• 7.1. Country Market Share Analysis, 2023 & 2030
• 7.2. Country Market Dashboard
• 7.3. Country Market Snapshot
• 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.5. U.S.
  • 7.5.1. Key country dynamics
  • 7.5.2. Regulatory framework
  • 7.5.3. Competitive scenario
  • 7.5.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Canada
  • 7.6.1. Key country dynamics
  • 7.6.2. Regulatory framework
  • 7.6.3. Competitive scenario
  • 7.6.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company/Competition Categorization
  • 8.1.1. Innovators
  • 8.1.2. Market Leaders
  • 8.1.3. Emerging Players
  • 8.1.4. Company Market Share Analysis, 2023
• 8.2. Company Profiles
  • 8.2.1. The Lubrizol Corporation
    • 8.2.1.1. Company overview
    • 8.2.1.2. Financial performance
    • 8.2.1.3. Product/service benchmarking
    • 8.2.1.4. Strategic initiatives
  • 8.2.2. Cambrex Corporation
    • 8.2.2.1. Company overview
    • 8.2.2.2. Financial performance
    • 8.2.2.3. Product/service benchmarking
    • 8.2.2.4. Strategic initiatives
  • 8.2.3. Contract Pharmaceuticals Limited
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Product/service benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. Bora Pharmaceutical CDMO
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Product/service benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. Ascendia Pharmaceuticals
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Product/service benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. Pierre Fabre S.A.
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Product/service benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. Piramal Pharma Solutions
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Product/service benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. DPT Laboratories, LTD.
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Product/service benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. MedPharm Ltd.
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Product/service benchmarking
    • 8.2.9.4. Strategic initiatives
  • 8.2.10. Zenvisionpharma
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Product/service benchmarking
    • 8.2.10.4. Strategic initiatives

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 Global Topical Drugs CDMO: Market Revenue Estimates and Forecast, 2018 - 2030 (USD Billion)
• Table 4 Global Topical Drugs: Market Revenue Estimates and Forecast, 2018 - 2030 (USD Billion)
• Table 5 Development Stages Baseline Model Parameter Estimates, By Topical Drugs
• Table 6 Global Topical Drugs CDMO Manufacturing Container Capacity/Batch
• Table 7 Global Topical Drugs Capacity, by Product Type (per unit)
• Table 8 Global Topical Drugs Capacity, by Container Type (per unit)
• Table 9 North America Topical Drugs CDMO Market Share, By Product Category, 2023 (%)
• Table 10 List of Major Prescription Drugs, by Product Type (2022)
• Table 11 List of Major Generic Drugs, by Product Type (2022)
• Table 12 List of major OTC Drugs, by Product Type (2022)
• Table 13 North America Topical Drugs CDMO market revenue estimates and forecast, by Product type, 2018 - 2030 (USD Million)
• Table 14 North America Topical Drugs CDMO market revenue estimates and forecast, by Semi-solid formulations, 2018 - 2030 (USD Million)
• Table 15 North America Topical Drugs CDMO market revenue estimates and forecast, by Liquid formulations drugs, 2018 - 2030 (USD Million)
• Table 16 North America Topical Drugs CDMO market revenue estimates and forecast, by service type, 2018 - 2030 (USD Million)
• Table 17 North America Topical Drugs CDMO market revenue estimates and forecast, by contract development, 2018 - 2030 (USD Million)
• Table 18 North America Topical Drugs CDMO market revenue estimates and forecast, by contract manufacturing, 2018 - 2030 (USD Million)
• Table 19 North America Topical Drugs CDMO market revenue estimates and forecast, by sponsors, 2018 - 2030 (USD Million)
• Table 20 North America Topical Drugs CDMO market revenue estimates and forecast, by country, 2018 - 2030 (USD Million)
• Table 21 Company profiles: Company overview
• Table 22 Company profiles: Financial performance
• Table 23 Company profiles: Service benchmarking
• Table 24 Key Company initiating service launches/upgrades
• Table 25 Key companies initiating mergers/acquisitions/joint ventures
• Table 26 Key companies initiating partnerships
• Table 27 Key companies initiating expansion
• Table 28 Key companies initiating others 

List of Figures

• Fig. 1 North America topical drugs CDMO market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 QFD modeling for market share assessment
• Fig. 7 Market formulation & validation
• Fig. 8 Commodity flow analysis
• Fig. 9 Market snapshot
• Fig. 10 Segment snapshot
• Fig. 11 Competitive landscape snapshot
• Fig. 12 Global topical drugs CDMO market outlook, 2023 (USD Billion)
• Fig. 13 Global topical drugs market outlook, 2023 (USD Billion)
• Fig. 14 North America topical drugs CDMO market dynamics
• Fig. 15 Porter's Five Forces analysis
• Fig. 16 SWOT analysis, by factor (political & legal, economic and technological)
• Fig. 17 North America Topical Drugs CDMO market: Product Type outlook and key takeaways
• Fig. 18 North America Topical Drugs CDMO market: Product Type movement analysis
• Fig. 19 Semi-solid formulations market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 20 Creams market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 21 Ointments market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 22 Lotions market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 23 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 24 Liquid formulations market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 25 Suspensions market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 26 Solutions market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 27 Solid formulations market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 28 Transdermal products market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 29 North America Topical Drugs CDMO market: Service type outlook and key takeaways
• Fig. 30 North America Topical Drugs CDMO market: Service type movement analysis
• Fig. 31 Contract development market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 32 Formulation development market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 33 Analytical testing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 34 Stability testing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 35 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 36 Contract manufacturing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 37 Clinical market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 38 Commercial market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 39 North America Topical Drugs CDMO market: sponsors outlook and key takeaways
• Fig. 40 North America Topical Drugs CDMO market: sponsors movement analysis
• Fig. 41 Pharmaceutical companies market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 42 Biopharmaceutical companies market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 43 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 44 North America Topical Drugs CDMO market revenue, by country, 2023 & 2030 (USD Million)
• Fig. 45 Regional outlook, 2023 & 2030
• Fig. 46 Regional Market Share Analysis, 2023 & 2030
• Fig. 47 North America Topical Drugs CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 48 Key country dynamics
• Fig. 49 U.S. Topical Drugs CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 50 Key country dynamics
• Fig. 51 Canada Topical Drugs CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 52 Market participant categorization
• Fig. 53 Market participant categorization
• Fig. 54 Heat map analysis